DE602006006950D1 - Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis - Google Patents

Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis

Info

Publication number
DE602006006950D1
DE602006006950D1 DE602006006950T DE602006006950T DE602006006950D1 DE 602006006950 D1 DE602006006950 D1 DE 602006006950D1 DE 602006006950 T DE602006006950 T DE 602006006950T DE 602006006950 T DE602006006950 T DE 602006006950T DE 602006006950 D1 DE602006006950 D1 DE 602006006950D1
Authority
DE
Germany
Prior art keywords
dermatitis
kit
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006006950T
Other languages
English (en)
Inventor
Laura Magee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Publication of DE602006006950D1 publication Critical patent/DE602006006950D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/45—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
DE602006006950T 2005-09-09 2006-09-08 Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis Active DE602006006950D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71564705P 2005-09-09 2005-09-09
US11/464,986 US20070059268A1 (en) 2005-09-09 2006-08-16 Compositions, methods and kits for treating allergic dermatitis of skin

Publications (1)

Publication Number Publication Date
DE602006006950D1 true DE602006006950D1 (de) 2009-07-09

Family

ID=37654805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006006950T Active DE602006006950D1 (de) 2005-09-09 2006-09-08 Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis

Country Status (7)

Country Link
US (1) US20070059268A1 (de)
EP (1) EP1762227B1 (de)
JP (1) JP2007084538A (de)
AU (1) AU2006208422A1 (de)
BR (1) BRPI0603774A (de)
CA (1) CA2559279A1 (de)
DE (1) DE602006006950D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
US7906149B2 (en) 2007-05-25 2011-03-15 Boval Company, L.P. Method for treating allergic dermatitis
US9909098B2 (en) * 2007-08-06 2018-03-06 The Regents Of The University Of California Methods of tissue-based diagnosis
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
FR2920309B1 (fr) * 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
ES2568605T3 (es) 2009-02-13 2016-05-03 The Regents Of The University Of California Composición y método para diagnóstico basado en tejido
WO2015042110A1 (en) * 2013-09-20 2015-03-26 Children's Medical Center Corporation Treatment of inflammatory skin disease
US11154486B2 (en) * 2020-02-14 2021-10-26 William M. Yarbrough Foundation Detergent compositions for washing urushiol and methods of treating urushiol induced contact dermatitis
US11191708B2 (en) * 2020-02-17 2021-12-07 William M. Yarbrough Foundation Sodium lauroyl sarcosinate containing detergent compositions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431743A (en) * 1978-03-16 1984-02-14 Cornell Research Foundation, Inc. Method for determining steroids in human body liquids
US4178373A (en) * 1978-08-21 1979-12-11 William H. Rorer, Inc. Coal tar gel composition
US4960467A (en) * 1985-02-11 1990-10-02 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
FR2700010B1 (fr) * 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
AU7604698A (en) * 1997-06-04 1998-12-21 Procter & Gamble Company, The Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants
IL140493A0 (en) * 1998-06-24 2002-02-10 Transderm Diagnostics Inc Non-invasive transdermal detection of analytes
KR100689725B1 (ko) * 1998-08-18 2007-03-09 덤테크 인터내셔널 표피에서 생물학적 인자를 검출하는 방법
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
US6423746B1 (en) * 1999-07-03 2002-07-23 The William M. Yarbrough Foundation Urushiol induced contact dermatitis and method of use
US7008963B2 (en) * 1999-07-03 2006-03-07 The William M. Yarbrough Foundation Urushiol induced contact dermatitis solution
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
US7547456B2 (en) * 2001-03-16 2009-06-16 Johnson & Johnson Consumer Companies, Inc. Composition containing feverfew extract and use thereof
US20030068663A1 (en) * 2001-09-06 2003-04-10 Kelly Huang Method and kit for measuring skin inflammation or irritation
US6803056B2 (en) * 2001-09-14 2004-10-12 Terence M. Dolak Method and composition for treating viral outbreaks
JP5068425B2 (ja) * 2002-05-02 2012-11-07 イーエルシー マネージメント エルエルシー 植物抽出物の生物学的活性の増強方法
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
US6812832B2 (en) * 2002-11-26 2004-11-02 General Motors Corporation Vehicle communication system with integrated pre-impact sensing
AU2002351219A1 (en) * 2002-12-04 2004-06-30 The William Yarbrough Foundation Urushiol induced contact dermatitis treatment and method of use
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient

Also Published As

Publication number Publication date
BRPI0603774A (pt) 2007-05-02
EP1762227A2 (de) 2007-03-14
US20070059268A1 (en) 2007-03-15
JP2007084538A (ja) 2007-04-05
EP1762227A3 (de) 2007-03-21
AU2006208422A1 (en) 2007-03-29
CA2559279A1 (en) 2007-03-09
EP1762227B1 (de) 2009-05-27

Similar Documents

Publication Publication Date Title
DE602006006950D1 (de) Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE461990T1 (de) Zusammensetzung für die gewebepflege
ZA201201391B (en) Methods, compositions, and kits for the treatment of medical conditions
WO2006124748A3 (en) Multicyclic compounds and methods of their use
DE602005011279D1 (de) Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
DE602005019640D1 (de) Zusammensetzungen zur Wäschebehandlung
DE602005014252D1 (de) Zusammensetzungen zur wäschebehandlung
EP1973526A4 (de) Neue haarbehandlungszusammensetzungen
ATE510595T1 (de) Haarbehandlungszusammensetzungen
DE602005015963D1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
ATE504334T1 (de) Haarbehandlungszusammensetzungen
TW200716088A (en) Formulations and methods for treating amyloidosis
GB2445674B (en) Compositions for the topical treatment of eczema, psoriasis and the like
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ZA200706662B (en) Haloaryl substituted Aminopurines, compositions thereof, and methods of treatment therewith
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
ATE447928T1 (de) Schweisshemmende oder desodorierende zusammensetzungen
DE602006021192D1 (de) Visnadin zur Behandlung von Kopfhautjucken
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.
DE602006006777D1 (de) Zusammensetzung und damit zusammenhängender Prozess
DE602007008759D1 (de) Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel
EP1865952A4 (de) Histaminhaltige zusammensetzung zur behandlung von allergischen erkrankungen
DE602006001128D1 (de) Alkylcycloheptylmethylcarbonate und Riechstoffkompositionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition